期刊
CANCER
卷 103, 期 12, 页码 2435-2446出版社
WILEY
DOI: 10.1002/cncr.21123
关键词
colorectal carcinoma; epidermal growth factor receptor; IMC-C225; cetuximab; bevacizumab; targeted chemotherapy
类别
Substantial effort has focused on the development of novel targeted agents for treating patients with late-stage colorectal carcinoma. These agents are designed specifically to inhibit biochemical processes associated with pathogenesis. Numerous molecules targeting the epidermal growth factor receptor have been investigated as therapeutic agents and appear to herald a shift in the treatment paradigm for colorectal carcinoma. (c) 2005 American Cancer Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据